179 related articles for article (PubMed ID: 35345275)
21. Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India.
Seth S; Thatai D; Sharma S; Chopra P; Talwar KK
Eur J Heart Fail; 2004 Oct; 6(6):723-9. PubMed ID: 15542407
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.
Mogensen J; Kubo T; Duque M; Uribe W; Shaw A; Murphy R; Gimeno JR; Elliott P; McKenna WJ
J Clin Invest; 2003 Jan; 111(2):209-16. PubMed ID: 12531876
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.
Kaski JP; Syrris P; Burch M; Tomé-Esteban MT; Fenton M; Christiansen M; Andersen PS; Sebire N; Ashworth M; Deanfield JE; McKenna WJ; Elliott PM
Heart; 2008 Nov; 94(11):1478-84. PubMed ID: 18467357
[TBL] [Abstract][Full Text] [Related]
24. The novel αB-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy.
Brodehl A; Gaertner-Rommel A; Klauke B; Grewe SA; Schirmer I; Peterschröder A; Faber L; Vorgerd M; Gummert J; Anselmetti D; Schulz U; Paluszkiewicz L; Milting H
Hum Mutat; 2017 Aug; 38(8):947-952. PubMed ID: 28493373
[TBL] [Abstract][Full Text] [Related]
25. Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.
Du J; Liu J; Feng HZ; Hossain MM; Gobara N; Zhang C; Li Y; Jean-Charles PY; Jin JP; Huang XP
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2604-13. PubMed ID: 18408133
[TBL] [Abstract][Full Text] [Related]
26. [Restrictive cardiomyopathy].
Wachter R; Pieske B
Herz; 2005 Sep; 30(6):558-64. PubMed ID: 16170689
[TBL] [Abstract][Full Text] [Related]
27. [Myocardiopathies (XI). Restrictive myocardiopathy: concept, classification, and clinical approach].
Huelmos A; Barba J; Martínez-Caro D
Rev Esp Cardiol; 1996 Jul; 49(7):523-31. PubMed ID: 8754447
[TBL] [Abstract][Full Text] [Related]
28. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
Seferović PM; Paulus WJ
Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
[TBL] [Abstract][Full Text] [Related]
29. Genetic Restrictive Cardiomyopathy: Causes and Consequences-An Integrative Approach.
Cimiotti D; Budde H; Hassoun R; Jaquet K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429969
[TBL] [Abstract][Full Text] [Related]
30. Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy.
Davis J; Yasuda S; Palpant NJ; Martindale J; Stevenson T; Converso K; Metzger JM
J Mol Cell Cardiol; 2012 Sep; 53(3):446-57. PubMed ID: 22683325
[TBL] [Abstract][Full Text] [Related]
31. [Restrictive cardiomyopathy].
Langlard JM
Arch Mal Coeur Vaiss; 1998 Dec; 91(12 Suppl):59-64. PubMed ID: 9891823
[TBL] [Abstract][Full Text] [Related]
32. Variant R94C in
Ezekian JE; Clippinger SR; Garcia JM; Yang Q; Denfield S; Jeewa A; Dreyer WJ; Zou W; Fan Y; Allen HD; Kim JJ; Greenberg MJ; Landstrom AP
J Am Heart Assoc; 2020 Mar; 9(5):e015111. PubMed ID: 32098556
[TBL] [Abstract][Full Text] [Related]
33. Generation of human induced pluripotent stem cell line from a patient with restrictive cardiomyopathy.
Li J; Jiang J; Ye L; Lian Z; Gong H; Lei W; Dai Y; Hu S
Stem Cell Res; 2024 Apr; 76():103370. PubMed ID: 38428347
[TBL] [Abstract][Full Text] [Related]
34. Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling.
Davis J; Wen H; Edwards T; Metzger JM
Circ Res; 2007 May; 100(10):1494-502. PubMed ID: 17463320
[TBL] [Abstract][Full Text] [Related]
35. Role of Whole-exome Sequencing in Phenotype Classification and Clinical Treatment of Pediatric Restrictive Cardiomyopathy.
Ding WH; Han L; Xiao YY; Mo Y; Yang J; Wang XF; Jin M
Chin Med J (Engl); 2017 Dec; 130(23):2823-2828. PubMed ID: 29176140
[TBL] [Abstract][Full Text] [Related]
36. Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies.
Vio R; Angelini A; Basso C; Cipriani A; Zorzi A; Melacini P; Thiene G; Rampazzo A; Corrado D; Calore C
J Clin Med; 2021 May; 10(9):. PubMed ID: 34062949
[TBL] [Abstract][Full Text] [Related]
37. Pediatric Restrictive Cardiomyopathies.
Ditaranto R; Caponetti AG; Ferrara V; Parisi V; Minnucci M; Chiti C; Baldassarre R; Di Nicola F; Bonetti S; Hasan T; Potena L; Galiè N; Ragni L; Biagini E
Front Pediatr; 2021; 9():745365. PubMed ID: 35145940
[TBL] [Abstract][Full Text] [Related]
38. Molecular Characterization of Pediatric Restrictive Cardiomyopathy from Integrative Genomics.
Rindler TN; Hinton RB; Salomonis N; Ware SM
Sci Rep; 2017 Jan; 7():39276. PubMed ID: 28098235
[TBL] [Abstract][Full Text] [Related]
39. Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach.
Pinto JR; Yang SW; Hitz MP; Parvatiyar MS; Jones MA; Liang J; Kokta V; Talajic M; Tremblay N; Jaeggi M; Andelfinger G; Potter JD
J Biol Chem; 2011 Jun; 286(23):20901-12. PubMed ID: 21502316
[TBL] [Abstract][Full Text] [Related]
40. Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery.
Wang BZ; Nash TR; Zhang X; Rao J; Abriola L; Kim Y; Zakharov S; Kim M; Luo LJ; Morsink M; Liu B; Lock RI; Fleischer S; Tamargo MA; Bohnen M; Welch CL; Chung WK; Marx SO; Surovtseva YV; Vunjak-Novakovic G; Fine BM
Cell Rep Med; 2023 Mar; 4(3):100976. PubMed ID: 36921598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
